Cite
HARVARD Citation
Mikami, D. et al. (2020). AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis via HDAC inhibition. Therapeutic advances in medical oncology. p. . [Online].